Coccidiosis in Chickens: Etiology, Clinical Management, and Control Strategies

Introduction

Coccidiosis is an economically devastating enteric disease of chickens caused by apicomplexan parasites of the genus Eimeria. The disease is characterized by destruction of intestinal epithelium, leading to malabsorption, hemorrhage, reduced weight gain, and increased mortality. Global poultry production losses attributable to coccidiosis are substantial, with costs arising from mortality, reduced feed conversion, medication, and vaccination [1]. The etiological agents are host-specific, with seven recognized species infecting chickens: Eimeria tenella, Eimeria necatrix, Eimeria acervulina, Eimeria maxima, Eimeria brunetti, Eimeria mitis, and Eimeria praecox [1]. Among these, E. tenella and E. necatrix are the most pathogenic [2, 32]. A cryptic species, Eimeria zaria, has also been characterized in chickens, with distinct ionophore susceptibility profiles [25]. Understanding the etiology, pathophysiology, and evidence-based management of this parasitic disease remains a priority for veterinary practitioners and poultry scientists.

Etiology and Life Cycle

Eimeria Species Diversity

Chicken Eimeria species are obligate intracellular parasites with a monoxenous life cycle. Each species exhibits a predilection for specific intestinal segments. E. tenella parasitizes the ceca, E. necatrix the midgut, E. acervulina the duodenum, E. maxima the jejunum and midgut, E. brunetti the lower intestine and rectum, E. mitis the entire small intestine, and E. praecox the upper small intestine [1]. The spatial proteome of invasive stages has been characterized, revealing proteins localized to key invasion organelles such as micronemes, rhoptries, and dense granules [3]. The microneme protein EtMIC2 facilitates E. tenella invasion by binding to the ITGAV receptor on host cells, concurrently inhibiting host cell apoptosis [4]. Molecular characterization of microneme protein 3 from E. necatrix has demonstrated immunoprotective potential [5]. Integrative comparative genomics and transcriptomics have identified SAG17 and SAG23 as key factors in early-stage virulence divergence of E. tenella [6].

Life Cycle Stages

The life cycle comprises three phases: sporulation (exogenous), schizogony (asexual endogenous), and gametogony (sexual endogenous). Unsporulated oocysts are shed in feces. Under appropriate temperature, humidity, and oxygen, they sporulate to become infective [7, 35]. Upon ingestion of sporulated oocysts, sporozoites are released in the gizzard and intestine, invade epithelial cells, and undergo merogony. Merozoites released from schizonts invade new cells, and after several generations, gametocytes form. Fertilization yields unsporulated oocysts, completing the cycle. The prepatent period ranges from 4 to 7 days depending on species [1]. Differential induction of host cell autophagy by virulent and precocious strains of E. tenella has been observed in vitro and in vivo, with implications for pathogenesis and vaccine development [32].

The following table summarizes the major pathogenic species, their intestinal location, and relative pathogenicity.

Epidemiology

Transmission occurs via the fecal-oral route. Oocysts are highly resistant to environmental conditions and can persist in litter, soil, and on equipment [35]. Environmental contamination modeling in broiler farms in Algeria demonstrated that oocyst counts are influenced by litter management, stocking density, and cleaning protocols [35]. Optimization of DNA extraction protocols from chicken feces has enabled accurate quantification of Eimeria species using real-time PCR, facilitating epidemiological surveillance [7].

Co-infections with other pathogens modulate disease severity. For example, the feed-borne mycotoxin deoxynivalenol interacts synergistically with mixed-species Eimeria challenge in layer pullets, exacerbating intestinal damage and impairing the transition to lay [30]. Risk factors also include elevated ambient temperature, feed withdrawal, and coccidiosis co-infection, which together increase oxidative stress and intestinal permeability [27].

Clinical Signs and Pathology

Clinical signs vary with infecting species, oocyst dose, age, and immune status. Typical manifestations include diarrhea (often mucoid or hemorrhagic), ruffled feathers, depression, anorexia, dehydration, and reduced growth rate [1]. In E. tenella infection, cecal hemorrhage is prominent, leading to high mortality in severe cases. E. necatrix causes intestinal ballooning and white plaques, with hemorrhagic enteritis [2, 8]. Subclinical infections are common in broilers, resulting in impaired feed conversion and uneven growth.

Pathologically, Eimeria infection induces Toll-like receptor-mediated innate immune responses that correlate with species-specific pathogenicity [2]. The TRAF6 molecule, a target of gga-miR-7b, promotes E. tenella-induced inflammation and apoptosis by activating the NF-kappaB pathway in chicken cells [9]. Supplementation with 5-aminolevulinic acid suppressed body weight loss and reduced disease severity during E. tenella infection in broilers [10]. Phytogenic interventions, such as Gentiana scabra extract, have been shown to mitigate E. tenella-induced coccidiosis by regulating the gut microbiota-metabolome and strengthening the intestinal barrier [11]. Similarly, Stemona tuberosa exhibits anticoccidial activity in vivo and in vitro, with associated host intestinal protection [33].

Diagnosis

Definitive diagnosis relies on detection and identification of Eimeria oocysts, lesions, or parasitic DNA. Standard methods include:

• Necropsy and lesion scoring: Observation of characteristic intestinal lesions (e.g., cecal cores in E. tenella, white plaques in E. necatrix). Lesion scoring (0 to 4) is used for severity assessment.
• Fecal flotation and microscopy: Oocysts are concentrated using saturated NaCl or sugar solutions. Morphological features (shape, size, presence of micropyle) provide preliminary species identification [1].
• Molecular diagnostics: Quantitative real-time PCR (qPCR) assays enable species-specific quantification from fecal samples. Optimized DNA extraction protocols improve assay sensitivity [7]. Cross-priming amplification (CPA) combined with lateral flow immunoassay biosensors allows rapid genus-level detection and identification of the four most economically important species (E. tenella, E. necatrix, E. acervulina, E. maxima) [12].
• In vitro bioluminescence assays: A bioluminescence-based in vitro assay has been developed for rapid and quantitative anticoccidial screening, providing a high-throughput alternative to animal trials [31].

Diagnostic workup should differentiate coccidiosis from other causes of enteritis, such as necrotic enteritis (Clostridium perfringens) and bacterial infections. The presence of oocysts alone does not confirm clinical disease; quantitative assessment and lesion correlation are essential [7].

Treatment: Chicken Coccidia Meds

Pharmacological management of coccidiosis has historically relied on two major drug classes: ionophore antibiotics and synthetic chemicals. However, widespread resistance has emerged, necessitating careful rotation and combination strategies [8, 13]. The term "chicken coccidia meds" encompasses these anticoccidial agents, as well as botanicals and probiotics.

Ionophore Antibiotics

Ionophores (e.g., monensin, salinomycin, narasin) disrupt ion gradients across Eimeria cell membranes, impairing sporozoite and merozoite development. Narasin combined with diclazuril has been evaluated as a feed additive and found safe and efficacious for chickens for fattening [14]. Ionophore susceptibility varies among species; Eimeria zaria has been characterized for the first time regarding its ionophore susceptibility profile [25]. Resistance to maduramycin is associated with phosphoglycerate mutase 1 (PGM1), which is implicated in host cell invasion by E. tenella [13].

Synthetic Chemical Drugs

Synthetic anticoccidials include triazines (toltrazuril), sulfonamides (sulfaclozine, sulfamidine-diaveridine combinations), and benzacetonitriles (diclazuril). Evaluation of toltrazuril and sulfaclozine resistance in chicken coccidiosis in Vietnam demonstrated reduced efficacy and delayed intestinal recovery [8]. The sulfamidine-diaveridine combination showed therapeutic efficacy against Vietnamese field isolates of Eimeria spp. in broilers [15].

Phytogenic and Alternative Agents

Numerous plant-derived compounds have been investigated as alternatives or adjuncts to conventional drugs. Lavender essential oil (Lavandula angustifolia) demonstrated anticoccidial activity in vitro and in vivo [16]. Eucalyptus oil microcapsules and mangosteen extract showed efficacy against E. tenella infection [28]. Oregano extracts, alone or combined with other biomolecules, improved growth performance and parasitological parameters in broilers challenged with Eimeria spp., as confirmed by meta-analysis [26]. Quercetin and thyme oil reduced oxidative stress biomarkers and altered mRNA expression of interleukins 6, 2, and 16 during E. tenella infection [17]. Red osier dogwood extract improved growth performance, protein digestibility, and gut health in a coccidiosis vaccine challenge model [18]. Curcumin modulated gut bacterial populations and NF-kappaB/NRF2 immune-redox responses in Eimeria-challenged broilers [19]. Saponin and polyphenol supplementation mitigated the effects of multiple stressors including coccidiosis [27]. Phytogenic feed additives in general have been shown to improve growth performance, gut health, and antioxidant capacity in broilers challenged with E. tenella [29]. Botanical feed additives also exert temporal effects under feed withdrawal periods prior to coccidiosis inoculation [20].

Probiotics and Prebiotics

Supplementation with Lactobacillus acidophilus and Enterococcus faecium, delivered in ovo or via drinking water, reduced Eimeria infection severity in broilers [21]. A meta-analysis of probiotic supplementation in coccidiosis-challenged broilers confirmed beneficial effects on growth and lesion scores [34].

Control Strategies

Integrated control programs combine chemoprophylaxis, vaccination, biosecurity, and management practices to reduce Eimeria exposure and build flock immunity.

Vaccination

Live vaccines, including virulent and attenuated (precocious) strains, are widely used. Subunit and DNA vaccines are under development. A chimeric multi-antigen fusion vaccine, EimeriaBig, induced immune responses and protective effects against E. necatrix [22]. A tetravalent recombinant subunit vaccine provided protection against mixed challenges with four Eimeria species [23]. A DNA vaccine based on E. maxima EF-1α antigen, co-expressing chicken XCL1 chemokine, enhanced immunoprotection [24]. Vaccination strategies must account for the interplay between nutritional stressors and immunity; for example, red osier dogwood extract improved outcomes in a vaccine challenge model [18].

Biosecurity and Management

Reducing environmental oocyst contamination is critical. Regular litter removal, disinfection with effective agents (e.g., ammonia, steam), and limiting stocking density lower challenge pressure. Risk modeling in broiler farms identifies litter moisture, temperature, and cleaning protocols as key predictors of coccidiosis outbreaks [35]. Feed withdrawal periods and elevated ambient temperature can exacerbate disease, so management should minimize stress [27].

Anticoccidial Rotation and Shuttle Programs

To slow resistance development, veterinarians often employ "shuttle" programs (different drugs in starter/grower feeds) or "rotation" (alternating drug classes between flocks). Monitoring drug efficacy through fecal oocyst counts and lesion scoring is essential [8, 15]. The emergence of resistance to toltrazuril and sulfaclozine in Vietnam highlights the need for ongoing surveillance [8].

Integrated Framework

The following Mermaid diagram illustrates a decision framework for coccidiosis control in broiler flocks.

flowchart TD
    A[Flock health monitoring], > B{Clinical signs present?}
    B, Yes, > C[Perform necropsy and lesion scoring]
    C, > D[Collect fecal samples for oocyst count and species ID]
    D, > E{Diagnosis confirmed?}
    E, Yes, > F[Implement treatment: anticoccidial drugs or alternatives]
    F, > G[Evaluate response: lesion re-scoring, oocyst reduction]
    G, > H{Resistance suspected?}
    H, Yes, > I[Switch drug class or adopt rotation/shuttle program]
    H, No, > J[Continue prevention: biosecurity, vaccination]
    E, No, > K[Rule out other enteropathogens (bacterial, viral)]
    B, No, > J
    J, > L[Environmental monitoring: litter oocyst counts, moisture, hygiene]
    L, > M[Adjust management: cleaning, stocking density, stress reduction]
    M, > A

Conclusion

Coccidiosis remains a persistent challenge in poultry production due to the high fecundity of Eimeria, environmental resilience of oocysts, and evolution of drug resistance. Effective management requires a multifaceted approach combining accurate diagnosis, judicious use of anticoccidial medications (including ionophores, synthetics, and emerging phytogenic and probiotic alternatives), vaccination, and rigorous biosecurity. The development of molecular diagnostics, including qPCR and CPA-based biosensors, has improved species identification and quantification. Continued research into parasite biology, host immune responses, and novel control agents is essential to sustain poultry health and productivity.

References

[1] Nguyen BT, Flores RA, Kim T et al. Understanding Eimeria infection for the treatment and prevention of chicken coccidian parasites. Front Cell Infect Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41969659/

[2] Zhu H, Zheng G, Wang D et al. Toll-like receptor-mediated innate immune response correlate with the pathogenicity of Eimeria tenella infection in SPF chickens. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42204750/

[3] Attree E, Barylyuk K, Noonan C et al. The spatial proteome of Eimeria tenella provides a high-resolution view of proteins localised to key invasion organelles. Int J Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42102995/

[4] Cui KL, Guo LL, Lei X et al. Pathogenic mechanism of Eimeria tenella EtMIC2 promotes Eimeria tenella invasion and inhibits host cell apoptosis through binding to the ITGAV receptor. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42025007/

[5] Feng Q, Yan D, Xue N et al. Molecular characterization and immunoprotective potential of microneme protein 3 from Eimeria necatrix. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42069683/

[6] He Y, Wan X, Wang X et al. Integrative comparative genomics and transcriptomics reveal key roles of SAG17 and SAG23 in early-stage virulence divergence of Eimeria tenella. Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42050698/

[7] Jung HR, Her M, Yun CS et al. Development of optimized DNA extraction protocols for the quantification of Eimeria spp. from chicken feces using real-time PCR. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42068766/

[8] Na TT, Hoa NT, Hung PHS et al. Evaluation of Toltrazuril and Sulfaclozine resistance in chicken coccidiosis in Vietnam and its impact on intestinal recovery. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42171921/

[9] Tang J, Zhang J, Tang M et al. TRAF6, a gga-miR-7b Target, Promotes Eimeria tenella-Induced Inflammation and Apoptosis in Chickens by Activating NF-κB Pathway. Biomolecules. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42194006/

[10] Hanif TA, Matsubayashi M, Hatabu T. Supplementation of 5-Aminolevulinic Acid Suppressed Body Weight Loss and Reduced Disease Severity During Eimeria tenella Infection in Broiler Chickens. J Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42028132/

[11] Yuke Z, Chen X, Abuzeid AMI et al. Gentiana sc

[12] Wang YX, Wu ZX, Wang ZR et al. Cross-priming amplification strategy-assisted lateral flow immunoassay biosensors for the rapid detection of chicken Eimeria parasites at genus-level and identification of the four most economically important species. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42048791/

[13] Bai J, Zhao Q, Xiao K et al. Phosphoglycerate mutase 1 is implicated in maduramycin resistance and host cell invasion in Eimeria tenella. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41955695/

[14] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G et al. Safety and efficacy of a feed additive consisting of narasin and diclazuril (Interban®) for chickens for fattening and chickens reared for laying (Elanco GmbH). EFSA J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42016296/

[15] Pham HSH, Nguyen TH, Le DP et al. Evaluation of the therapeutic efficacy of the sulfamidine-diaveridine combination against Vietnamese field isolate of Eimeria spp. in broiler chickens. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41962192/

[16] Iqbal S, Tanveer S, Allaqaband SM et al. Lavender essential oil as a novel anticoccidial agent: First report from in-vitro and in-vivo studies of Lavandula angustifolia flowering plant grown in the Kashmir Himalayas. Microb Pathog. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42061661/

[17] Mohamed RA, Ali HA, Salem GA et al. Assessment of Quercetin and Thyme Oil Effect on Oxidative Stress Biomarkers and mRNA Expressions of Interleukin 6, 2, and 16 During Eimeria tenella Infection. Avian Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41973004/

[18] Santos Reis Pereira I, I Adewole D. Effects of red osier dogwood extract on growth performance, protein digestibility, tibia breaking strength, immune response, and gut health of broiler chickens in a coccidiosis vaccine challenge model. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42105386/

[19] Abdulhusein HM, Taherpour K, Ghasemi HA et al. Curcumin modulates targeted gut bacterial populations and NF-κB/NRF2 immune-redox responses in Eimeria-challenged broilers fed soybean or canola oil. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42252365/

[20] Froebel LE, Watson BY, Rincker MJ et al. Temporal effects of a botanical feed additive and experimental housing methods in broilers exposed to an acute feed withdrawal period prior to coccidiosis inoculation. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42019473/

[21] Aydin R, Tegün E, Özüiçli M et al. Efficacy of in ovo and drinking water delivery of Lactobacillus acidophilus and Enterococcus faecium against Eimeria infection in broiler chickens. Exp Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42092525/

[22] Chen X, Cai H, Liao S et al. Construction of a chimeric multi-antigen fusion vaccine, EimeriaBig, and evaluation of immune response and protective effect in Eimeria necatrix. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42214189/

[23] Ma X, Zhang X, Li J et al. A Tetravalent Recombinant Subunit Vaccine Provides Protection Against Mixed Challenges with Four Eimeria Species in Chickens. Animals (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41976065/

[24] Lin XF, Wang XG, Fu CS et al. Evaluation of Immunoprotective Effects of DNA Vaccine Based on Eimeria maxima EF-1α Antigen and Chicken XCL1 Chemokine. Animals (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41976087/